济民健康称存在市场情绪过热及非理性炒作的情形

Group 1 - The core point of the article is that Jimin Health (603222) experienced a significant stock price increase of 53.78% from August 13 to August 19, with multiple instances of trading anomalies [1] - On August 20, the company's stock hit the daily limit again, with a turnover rate of 31.31%, both indicators significantly exceeding the industry average during the same period [1] - Jimin Health stated that there have been no major changes in its fundamentals, indicating that the market sentiment is overly heated and there is irrational speculation, leading to a notable "hot potato" effect in trading [1] Group 2 - The company reported a decline in revenue for the first half of 2025, with operating income of 366 million yuan, a year-on-year decrease of 21.3% [1] - The net profit attributable to shareholders was -52.6959 million yuan, indicating a shift from profit to loss compared to the previous year [1] - The company acknowledged the potential for significant trading risks due to the large short-term price increase, suggesting that the stock may face considerable downward pressure in the future [1]